0001812173 false 0001812173 2022-06-01 2022-06-01 0001812173 RBOT:ClassCommonStockParValue0.0001PerShareMember 2022-06-01 2022-06-01 0001812173 RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember 2022-06-01 2022-06-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 1, 2022

 

 

 

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39384   87-2678169
(State or other jurisdiction of
incorporation)		   (Commission File Number)  

(IRS Employer
Identification No.)

 

78 Fourth Avenue
Waltham, Massachusetts 		  02451
(Address of principal executive offices)   (Zip Code)  

 

Registrant’s telephone number, including area code: (617) 868-1700

 

N/A

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Class A common stock, par value $0.0001 per share   RBOT   The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share   RBOT WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(e)On June 1, 2022, the stockholders of Vicarious Surgical Inc. (the “Company”) approved an amendment to the Company’s 2021 Equity Incentive Plan (the “2021 Plan”) that includes the following material changes:

 

●The aggregate number of shares of our common stock that may be issued under the 2021 Plan is increased by 6,590,000 shares, subject to adjustment for certain changes in our capitalization.

 

●The aggregate maximum number of shares of our common stock that may be issued pursuant to the exercise of incentive stock options under the 2021 Plan is increased by 6,590,000 shares, subject to adjustment for certain changes in our capitalization.

 

A detailed summary of the material features of the 2021 Plan is set forth in the Company’s definitive proxy statement for its 2022 annual meeting of stockholders filed with the Securities and Exchange Commission on April 29, 2022. That summary and the foregoing description is qualified in its entirety by reference to the text of the 2021 Plan, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

(a)On June 1, 2022, the Company held its 2022 annual meeting of stockholders. Of 497,185,995 votes outstanding as of the record date of April 11, 2022, a quorum of at least 434,382,111 votes, or 87.36% of the votes outstanding and entitled to be cast at the meeting, were present or represented by proxy.

 

(b)The following actions were taken at such meeting:

 

1.The following nominees were elected to serve on the Company’s board of directors until the Company’s 2023 annual meeting of stockholders, based on the following votes:

 

Nominee  Votes
For		   Votes
Withheld		   Broker
Non-Votes		 
Adam Sachs   422,854,488    2,032,064    9,495,559 
Sammy Khalifa   422,604,385    2,282,167    9,495,559 
David Styka   422,186,615    2,699,937    9,495,559 
Dror Berman   422,768,297    2,118,255    9,495,559 
Ric Fulop   422,767,287    2,119,265    9,495,559 
David Ho   423,640,708    1,245,844    9,495,559 
Samir Kaul   421,813,514    3,073,038    9,495,559 
Philip Liang   421,469,110    3,417,442    9,495,559 
Donald Tang   424,533,208    353,344    9,495,559 

 

2.Approval of an amendment to the 2021 Plan, based on the following results:

 

Votes For   Votes Against   Abstentions   Broker Non-Votes
421,440,362   3,372,413   73,777   9,495,559

 

3.The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was ratified, based on the following results:

 

Votes For   Votes Against   Abstentions   Broker Non-Votes
434,324,362   26,477   31,272   0

 

Item 9.01 Financial Statements and Exhibits.

 

(d)Exhibits.

 

Exhibit No.   Description
10.1   Vicarious Surgical Inc. 2021 Equity Incentive Plan, as amended, and forms of agreement thereunder
104   Cover Page Interactive Data File (embedded with the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VICARIOUS SURGICAL INC.
   
  By: /s/Adam Sachs
  Name:  Adam Sachs
  Title: President and Chief Executive Officer

 

Date: June 3, 2022

 

 

2

 

 

D8 (NYSE:DEH)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more D8 Charts.
D8 (NYSE:DEH)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more D8 Charts.